Steve Grace
About Steve Grace
Steve Grace is an Oncology Account Manager at Bristol Myers Squibb with extensive experience in oncology and immunology across various pharmaceutical companies.
Current Role at Bristol Myers Squibb
Steve Grace is currently employed as an Oncology Account Manager at Bristol Myers Squibb. He brings a wealth of experience to the role, leveraging his extensive background in oncology and sales to effectively manage client relationships and support therapeutic advancements in the oncology space.
Previous Experience at Mirati Therapeutics
From 2022 to 2024, Steve Grace was employed at Mirati Therapeutics as an Oncology Account Manager in Chattanooga, Tennessee. During his tenure, he focused on oncology treatments, providing comprehensive account management services and fostering relationships with healthcare providers in the region.
Role at AstraZeneca as Senior Executive
Between 2015 and 2022, Steve Grace worked at AstraZeneca as a Senior Executive Immuno-Oncology Clinical Oncology Specialist, based in Tennessee. His role involved specialization in immuno-oncology, offering critical insights into the treatment of various tumor types and engaging in clinical support activities.
Experience in the Immunology and Rare Diseases Sector
From 2010 to 2015, Steve Grace served as a Senior Executive Account Manager in the Immunology and Rare Diseases Business Unit at GlaxoSmithKline. He was responsible for managing accounts and driving sales within this specialized sector, demonstrating his expertise in immunology.
Background and Education
Steve Grace earned a Bachelor of Science in Finance from the University of South Florida. He also participated in the Field Reimbursement Job Shadow/Development Program in 2014, further enhancing his skills in healthcare reimbursement and account management.
Expertise in Multiple Specialties
Steve Grace possesses expertise in a variety of medical specialties, including oncology, immuno-oncology, urology, immunology, and rheumatology. His experience spans covering geographies such as Middle and East Tennessee, Western North Carolina, and South Central Kentucky, focusing on tumor types like lung, breast, prostate, and urothelial/bladder.